- Home
- PYPD vs SPCB Comparison
PYPD vs SPCB Comparison
Compare PYPD & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- SPCB
- Stock Information
- Founded
- PYPD 2008
- SPCB 1988
- Country
- PYPD Israel
- SPCB Israel
- Employees
- PYPD N/A
- SPCB N/A
- Industry
- PYPD Medical/Dental Instruments
- SPCB Semiconductors
- Sector
- PYPD Health Care
- SPCB Technology
- Exchange
- PYPD Nasdaq
- SPCB Nasdaq
- Market Cap
- PYPD 60.4M
- SPCB 50.9M
- IPO Year
- PYPD 2020
- SPCB N/A
- Fundamental
- Price
- PYPD $3.63
- SPCB $10.72
- Analyst Decision
- PYPD Strong Buy
- SPCB Strong Buy
- Analyst Count
- PYPD 5
- SPCB 1
- Target Price
- PYPD $12.00
- SPCB $18.00
- AVG Volume (30 Days)
- PYPD 87.2K
- SPCB 71.9K
- Earning Date
- PYPD 11-12-2025
- SPCB 11-13-2025
- Dividend Yield
- PYPD N/A
- SPCB N/A
- EPS Growth
- PYPD N/A
- SPCB N/A
- EPS
- PYPD N/A
- SPCB 0.98
- Revenue
- PYPD N/A
- SPCB $27,426,000.00
- Revenue This Year
- PYPD N/A
- SPCB N/A
- Revenue Next Year
- PYPD N/A
- SPCB $29.31
- P/E Ratio
- PYPD N/A
- SPCB $10.41
- Revenue Growth
- PYPD N/A
- SPCB 2.17
- 52 Week Low
- PYPD $2.30
- SPCB $3.08
- 52 Week High
- PYPD $3.93
- SPCB $18.95
- Technical
- Relative Strength Index (RSI)
- PYPD 53.80
- SPCB 49.45
- Support Level
- PYPD $3.59
- SPCB $9.99
- Resistance Level
- PYPD $3.88
- SPCB $11.79
- Average True Range (ATR)
- PYPD 0.15
- SPCB 0.67
- MACD
- PYPD 0.02
- SPCB -0.06
- Stochastic Oscillator
- PYPD 67.95
- SPCB 46.57
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.